Notably, HOXC6 plays an important anti-apoptotic role by regulating BCL-2 expression [144,145] in human head and neck squamous cell carcinoma and cervical cancer, and suppressing NEP/MME and IGFBP-3 genes [146] in prostate cancer. This evidence concerns the gene MME and head and neck squamous cell carcinoma.